Influenza Infection in Ferrets with SARS-CoV-2 Infection History
暂无分享,去创建一个
J. V. D. van den Brand | J. de Jonge | Puck B. van Kasteren | Lisa A. Wijsman | H. V. van Dijken | Stefanie Lenz | C. V. B. de Melo | Koen van de Ven | Florence Peters | Angéla Gommersbach | Tanja Schouten | van den Brand Judith | Angéla Gomersbach | Caroline Vilas Boas de Melo | H. van Dijken | Jørgen de Jonge
[1] O. J. Peter,et al. Nonlinear optimal control strategies for a mathematical model of COVID-19 and influenza co-infection , 2022, Physica A: Statistical Mechanics and its Applications.
[2] R. Plemper,et al. SARS-CoV-2 variant of concern type and biological sex affect efficacy of molnupiravir in dwarf hamster model of severe COVID-19 , 2022, bioRxiv.
[3] P. Shah,et al. Immuno-proteomic profiling reveals aberrant immune cell regulation in the airways of individuals with ongoing post-COVID-19 respiratory disease , 2022, Immunity.
[4] B. Hoffmann,et al. Enhanced fitness of SARS-CoV-2 variant of concern Alpha but not Beta , 2021, Nature.
[5] T. Ross,et al. SARS-CoV-2 and Influenza A Virus Coinfections in Ferrets , 2021, Journal of virology.
[6] H. Li,et al. Immune signatures underlying post-acute COVID-19 lung sequelae , 2021, Science Immunology.
[7] Youliang Wang,et al. In vivo structure and dynamics of the SARS-CoV-2 RNA genome , 2021, Nature Communications.
[8] Soo-Young Lee,et al. The in vitro and in vivo efficacy of CT-P59 against Gamma, Delta and its associated variants of SARS-CoV-2 , 2021, Biochemical and Biophysical Research Communications.
[9] M. Netea,et al. Induction of trained immunity by influenza vaccination - impact on COVID-19 , 2021, medRxiv.
[10] J. Geddes,et al. Incidence, co-occurrence, and evolution of long-COVID features: A 6-month retrospective cohort study of 273,618 survivors of COVID-19 , 2021, PLoS medicine.
[11] R. Scheuermann,et al. Impact of SARS-CoV-2 variants on the total CD4+ and CD8+ T cell reactivity in infected or vaccinated individuals , 2021, Cell Reports Medicine.
[12] P. Roholl,et al. Pathology and Immunity After SARS-CoV-2 Infection in Male Ferrets Is Affected by Age and Inoculation Route , 2021, bioRxiv.
[13] Zhongjie Li,et al. Impact of COVID-19 outbreaks and interventions on influenza in China and the United States , 2021, Nature Communications.
[14] B. Cong,et al. Sequential infection with H1N1 and SARS-CoV-2 aggravated COVID-19 pathogenesis in a mammalian model, and co-vaccination as an effective method of prevention of COVID-19 and influenza , 2021, Signal Transduction and Targeted Therapy.
[15] K. Laurie,et al. Which influenza viruses will emerge following the SARS‐CoV‐2 pandemic? , 2021, Influenza and other respiratory viruses.
[16] P. Moore,et al. Therapeutic effect of CT-P59 against SARS-CoV-2 South African variant , 2021, bioRxiv.
[17] J. Min,et al. SARS-CoV-2 cell tropism and multiorgan infection , 2021, Cell discovery.
[18] H. Jäck,et al. SARS-CoV-2 variants B.1.351 and P.1 escape from neutralizing antibodies , 2021, Cell.
[19] Yu Chen,et al. Coinfection with influenza A virus enhances SARS-CoV-2 infectivity , 2021, Cell Research.
[20] E. Miska,et al. In vivo structural characterization of the SARS-CoV-2 RNA genome identifies host proteins vulnerable to repurposed drugs , 2021, Cell.
[21] H. Achdout,et al. Increased lethality in influenza and SARS-CoV-2 coinfection is prevented by influenza immunity but not SARS-CoV-2 immunity , 2021, Nature Communications.
[22] C. Turner,et al. Dose-dependent response to infection with SARS-CoV-2 in the ferret model and evidence of protective immunity , 2021, Nature Communications.
[23] I. Brown,et al. Intranasal Infection of Ferrets with SARS-CoV-2 as a Model for Asymptomatic Human Infection , 2021, Viruses.
[24] Jing Li,et al. H1N1 exposure during the convalescent stage of SARS-CoV-2 infection results in enhanced lung pathologic damage in hACE2 transgenic mice , 2021, Emerging microbes & infections.
[25] K. To,et al. Coinfection by Severe Acute Respiratory Syndrome Coronavirus 2 and Influenza A(H1N1)pdm09 Virus Enhances the Severity of Pneumonia in Golden Syrian Hamsters , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[26] T. Clark,et al. Physical distancing in schools for SARS-CoV-2 and the resurgence of rhinovirus , 2020, The Lancet Respiratory Medicine.
[27] Lisa E. Gralinski,et al. Animal models for COVID-19 , 2020, Nature.
[28] J. Greenbaum,et al. Antigen-Specific Adaptive Immunity to SARS-CoV-2 in Acute COVID-19 and Associations with Age and Disease Severity , 2020, Cell.
[29] Balraj Singh,et al. COVID-19 and Influenza Co-Infection: Report of Three Cases , 2020, Cureus.
[30] H. Ghasemzadeh-moghaddam,et al. High prevalence of SARS‐CoV‐2 and influenza A virus (H1N1) coinfection in dead patients in Northeastern Iran , 2020, Journal of medical virology.
[31] Angelo Carfì,et al. Persistent Symptoms in Patients After Acute COVID-19. , 2020, JAMA.
[32] Morten Nielsen,et al. Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild COVID-19 , 2020, Cell.
[33] Ji Yeun Kim,et al. SARS-CoV-2-Specific Antibody and T Cell Response Kinetics According to Symptom Severity , 2020, The American journal of tropical medicine and hygiene.
[34] P. Zhou,et al. The epidemiology and clinical characteristics of co‐infection of SARS‐CoV‐2 and influenza viruses in patients during COVID‐19 outbreak , 2020, Journal of medical virology.
[35] M. V. von Herrath,et al. Faculty Opinions recommendation of Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals. , 2020, Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature.
[36] R. Ozaras,et al. Influenza and COVID‐19 coinfection: Report of six cases and review of the literature , 2020, Journal of medical virology.
[37] Salvatore Ercolano,et al. The Efficacy of Lockdown Against COVID-19: A Cross-Country Panel Analysis , 2020, Applied Health Economics and Health Policy.
[38] J. Greenbaum,et al. Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals , 2020, Cell.
[39] H. Abad,et al. Co‐infection with COVID‐19 and influenza A virus in two died patients with acute respiratory syndrome, Bojnurd, Iran , 2020, Journal of medical virology.
[40] Hong Xu,et al. Non-pharmaceutical interventions used for COVID-19 had a major impact on reducing influenza in China in 2020 , 2020, Journal of travel medicine.
[41] M. Koopmans,et al. SARS-CoV-2 is transmitted via contact and via the air between ferrets , 2020, bioRxiv.
[42] Baoying Huang,et al. Susceptibility of ferrets, cats, dogs, and other domesticated animals to SARS–coronavirus 2 , 2020, Science.
[43] Eun-Ha Kim,et al. Infection and Rapid Transmission of SARS-CoV-2 in Ferrets , 2020, Cell Host & Microbe.
[44] Q. Ding,et al. The clinical characteristics of pneumonia patients coinfected with 2019 novel coronavirus and influenza virus in Wuhan, China , 2020, Journal of medical virology.
[45] R. Xavier,et al. Defining trained immunity and its role in health and disease , 2020, Nature Reviews Immunology.
[46] Wenling Wang,et al. The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice , 2020, Nature.
[47] Victor M Corman,et al. Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR , 2020, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.
[48] V. von Messling,et al. Ferret models of viral pathogenesis , 2015, Virology.
[49] A. Gruber,et al. Influenza A Viruses Target Type II Pneumocytes in the Human Lung , 2012, The Journal of infectious diseases.
[50] R. Rappuoli,et al. Efficacy of Vaccination with Different Combinations of MF59-Adjuvanted and Nonadjuvanted Seasonal and Pandemic Influenza Vaccines against Pandemic H1N1 (2009) Influenza Virus Infection in Ferrets , 2011, Journal of Virology.